Cellcept and Hepatic neoplasm - a phase IV clinical study of FDA data

Summary:

Hepatic neoplasm is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Prograf, and have Diabetes.

The phase IV clinical study analyzes which people have Hepatic neoplasm when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Hepatic neoplasm?

Hepatic neoplasm (liver tumour) is found to be associated with 489 drugs and 519 conditions by eHealthMe. Check the latest studies of Hepatic neoplasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 15 people (0.04%) have Hepatic neoplasm.

Among these 15 people:

How long have people been on Cellcept when they have Hepatic neoplasm? *

What is the gender of people who have Hepatic neoplasm when taking Cellcept? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Hepatic neoplasm when taking Cellcept? *

What are other drugs people take besides Cellcept? *

Neoral: 5 people, 33.33%
Prograf: 5 people, 33.33%
Hydrocodone Bitartrate And Acetaminophen: 4 people, 26.67%
Senna: 4 people, 26.67%
Multivitamin: 3 people, 20.00%
Sandimmune: 3 people, 20.00%
Prednisolone: 3 people, 20.00%
Fludara: 2 people, 13.33%
Diovan: 2 people, 13.33%
Cyclosporine: 2 people, 13.33%

What are other side effects people have besides Hepatic neoplasm? *

Focal Nodular Hyperplasia (tumour of the liver): 5 people, 33.33%
Fever: 4 people, 26.67%
Adenocarcinoma Pancreas (cancer of pancreas): 4 people, 26.67%
Hepatitis B Antibody Positive: 2 people, 13.33%
Blood Uric Acid Increased: 2 people, 13.33%
Hepatitis (inflammation of the liver): 2 people, 13.33%
Gamma-Glutamyltransferase Increased: 2 people, 13.33%
Epstein-Barr Virus Infection: 2 people, 13.33%
Cytomegalovirus Test Positive: 2 people, 13.33%
Cytomegalovirus Infection: 2 people, 13.33%

What are the existing conditions these people have? *

Renal Disorder (kidney disease): 3 people, 20.00%
Diabetes: 3 people, 20.00%
High Blood Pressure: 2 people, 13.33%
Rashes (redness): 1 person, 6.67%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 6.67%
Heart Transplant Rejection: 1 person, 6.67%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Hepatic neoplasm?

- Check whether Hepatic neoplasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic neoplasm:

Hepatic neoplasm (489 drugs)

Browse all the conditions that are associated with Hepatic neoplasm:

Hepatic neoplasm (519 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.